Rapid Onset Severe Immune Thrombocytopenia following mRNA COVID‐19 Vaccine in a Young Patient
Case Reports in Hematology, Volume 2023, Issue 1, 2023., 2023 The coronavirus disease 2019 (COVID‐19) pandemic has affected millions of people around the world. Vaccination against COVID‐19 has been approved for the following three vaccines in the United States: Pfizer‐BioNTech, Moderna, and Janssen. Hematological complications of vaccination have been reported in the literature but remain as a rare phenomenon ...
Jorge Avila +5 more
wiley +1 more source
Autoimmune Hemolytic Anemia and Immune Thrombocytopenia: A Unique Presentation of Kawasaki Disease
Case Reports in Rheumatology, Volume 2021, Issue 1, 2021., 2021 Kawasaki disease is an acute multisystem vasculitis characterized by involvement of medium‐sized vessels that mostly affects children under the age of 5 years. The presentation is typically preceded by five or more days of fever with additional clinical findings including rash, peripheral edema, mucositis, conjunctival changes, and unilateral cervical ...
Chloe Kupelian +3 more
wiley +1 more source
Epstein-Barr virus and skin [PDF]
Anais Brasileiros de Dermatologia, 2018 : Epstein-Barr virus is a DNA virus infecting human beings and could affect 90% of human population. It is crucial to take in account that in Latin America, unlike what happens in developed countries, the exposure to the virus is very early and therefore
Martin Sangueza-Acosta +1 more
doaj +2 more sources
The epidemiology of infectious mononucleosis in Northern Scotland : a decreasing incidence and winter peak [PDF]
, 2014 Peer reviewedPublisher ...
Collacott, Ian +5 more
core +2 more sources
Association between Herpesviruses and Chronic Periodontitis: A Meta-Analysis Based on Case-Control Studies [PDF]
, 2015 Objective Numerous studies have investigated the associations between herpesviruses and chronic periodontitis; however, the results remain controversial.
Feng, X +5 more
core +7 more sources
Epstein-Barr Virus as a promising immunotherapeutic target for nasopharyngeal carcinoma treatment [PDF]
, 2017 Epstein-Barr virus (EBV) is a pathogen that infects more than 90% of global human population. EBV primarily targets Blymphocytes and epithelial cells while some of them infect monocyte/macrophage, T-lymphocytes, and dendritic cells (DCs).
Peh, Suat Cheng * +2 more
core +2 more sources
Epstein-Barr Virus Coinfection in COVID-19
Journal of Investigative Medicine High Impact Case Reports, 2021 Epstein-Barr virus (EBV), a member of the herpes virus family, is a causative agent for infectious mononucleosis in young adults. It has an asymptomatic and subclinical distribution in about 90% to 95% of the world population based on seropositivity. EBV
Asim Nadeem MD +3 more
doaj +1 more source
Evidence for coordinated induction and repression of ecto-5'-nucleotidase (CD73) and the A2a adenosine receptor in a human B cell line [PDF]
, 2003 In the human B cell line P493-6 two mitogenic signals, the EpsteinBarr virus nuclear antigen 2 (EBNA2) and myc, can be independently regulated by means of an estrogen receptor fusion construct or an inducible expression vector, respectively.
Burgemeister R. +6 more
core +1 more source
Journal of Dr. NTR University of Health Sciences, 2019 Background and Aims: Head and neck cancer is the most common type of cancer in word wide and Oral squamous cell carcinoma (OSCC) accounts for 90% of oral cancers and it represents the sixth most frequent malignant tumour world wide.
M Mary Prathyusha +5 more
doaj +1 more source
Epstein-Barr Virus and Neurological Diseases
Frontiers in Molecular Biosciences, 2022 Epstein-Barr virus (EBV), also known as human herpesvirus 4, is a double-stranded DNA virus that is ubiquitous in 90–95% of the population as a gamma herpesvirus.
Nan Zhang +6 more
doaj +1 more source